Education
About Us
Working with TipRanks
Follow Us
RxSight (RXST)
NASDAQ:RXST
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 139.93M | $ 89.08M | $ 49.01M | $ 22.59M | $ 14.68M |
| Gross Profit | $ 98.94M | $ 53.77M | $ 21.33M | $ 4.52M | $ 1.71M |
| Operating Income | $ -36.86M | $ -50.09M | $ -63.32M | $ -52.79M | $ -35.41M |
| EBITDA | $ -23.76M | $ -41.04M | $ -57.78M | $ -41.01M | $ 32.15M |
| Net Income | $ -27.45M | $ -48.61M | $ -66.76M | $ -48.69M | $ 27.57M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 237.22M | $ 127.18M | $ 105.80M | $ 159.33M | $ 68.97M |
| Total Assets | $ 318.56M | $ 182.55M | $ 150.16M | $ 192.72M | $ 100.68M |
| Total Debt | $ 12.30M | $ 3.01M | $ 44.99M | $ 44.93M | $ 30.75M |
| Net Debt | $ -4.41M | $ -6.68M | $ 33.16M | $ 20.57M | $ 16.76M |
| Total Liabilities | $ 37.33M | $ 22.19M | $ 60.26M | $ 54.48M | $ 398.21M |
| Stockholders' Equity | $ 281.24M | $ 160.36M | $ 89.90M | $ 138.24M | $ -297.53M |
| Cash Flow | |||||
| Free Cash Flow | $ -22.39M | $ -46.41M | $ -61.24M | $ -46.65M | $ -37.74M |
| Operating Cash Flow | $ -16.95M | $ -41.59M | $ -58.85M | $ -44.71M | $ -35.20M |
| Investing Cash Flow | $ -99.31M | $ -22.13M | $ 39.95M | $ -81.91M | $ 15.59M |
| Financing Cash Flow | $ 123.32M | $ 61.52M | $ 6.33M | $ 137.34M | $ 25.24M |